Classification: Growth Hormone Releasing Hormone Analog Blend
Active substances:
- CJC 1295 No DAC 5 mg
- Ipamorelin 5 mg
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder/10 mg per vial (5mg each)
Pack size: 10 mg vial (2 mL)
Route: Subcutaneous Injection
Lab Tested: Check Lab Test Result
Dragon Pharma's advanced CJC 1295 No DAC/Ipamorelin blend represents the gold standard in growth hormone optimization for serious athletes. This sophisticated 5mg/5mg combination pairs a modified growth hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue to create powerful, pulsatile GH release that mimics the body's natural secretion patterns. Specifically engineered for maximum efficacy in muscle growth, fat loss, and recovery enhancement, this blend delivers professional-grade results.
This cutting-edge peptide combination brings together two complementary mechanisms for optimal growth hormone stimulation. CJC 1295 (without Drug Affinity Complex) acts as a potent GHRH analog that stimulates the pituitary gland, while Ipamorelin provides selective GH release without affecting cortisol or prolactin levels. According to research in the Journal of Endocrinology, this combination creates a synergistic effect that produces robust, physiological GH pulses ideal for body composition enhancement and performance optimization.
The Dragon Pharma CJC 1295 No DAC/Ipamorelin blend delivers comprehensive, multi-system benefits that address the core goals of serious athletes:
Proper dosing is essential for maximizing the pulsatile GH release characteristic of this advanced blend. Reconstitute with bacteriostatic water using gentle swirling until fully dissolved. Recommended dosing strategies include:
Administer subcutaneous injections in abdominal tissue on an empty stomach. Pre-bedtime injections align with natural GH pulses during deep sleep. The reputation of Dragon Pharma as a legit CJC-1295 No DAC/Ipamorelin supplier ensures consistent quality and reliable dosing with every vial.
This sophisticated blend operates through complementary pathways that create optimal growth hormone pulsatility. CJC 1295 No DAC functions as a potent GHRH analog that binds to pituitary receptors, stimulating GH synthesis and release. Without the DAC component, it provides pulsatile rather than continuous release. Ipamorelin acts as a ghrelin receptor agonist that works synergistically with GHRH to amplify GH pulses while maintaining selectivity that avoids unwanted hormonal effects. Together, they create a powerful, physiological GH release pattern ideal for body composition enhancement.
Both components of this blend have substantial research supporting their efficacy and safety profile. The combination has become the preferred protocol among advanced athletes and anti-aging practitioners due to its ability to produce significant, measurable improvements in body composition without the side effects associated with exogenous GH administration. The pulsatile release pattern mimics natural secretion, reducing the risk of receptor desensitization and maintaining long-term efficacy.
Cycles typically range from 8-16 weeks, with the option for longer durations due to the excellent safety profile. Effective protocols include:
The absence of receptor desensitization with this blend allows for flexible cycling strategies tailored to individual goals.
The CJC 1295 No DAC/Ipamorelin blend is exceptionally well-tolerated with minimal side effects reported:
These effects are generally mild, dose-dependent, and diminish with continued use. The selective nature of Ipamorelin prevents cortisol or prolactin elevations commonly seen with other peptides.
Dragon Pharma maintains pharmaceutical-grade standards for this advanced peptide blend, ensuring:
This commitment to quality makes Dragon Pharma a verified legit CJC-1295 No DAC/Ipamorelin supplier trusted by competitive athletes worldwide.
Unreconstituted vials should be stored refrigerated at 2-8°C (36-46°F) in their original packaging, protected from light. After reconstitution with bacteriostatic water, the solution remains stable for 4-6 weeks when refrigerated. Avoid freezing, temperature extremes above 25°C (77°F), or repeated temperature fluctuations. Always use aseptic technique when handling and administering to maintain sterility and peptide integrity.
Dragon Pharma's CJC 1295 No DAC/Ipamorelin combination offers distinct advantages for athletes seeking optimal results:
For serious athletes committed to achieving their peak physique, this advanced peptide blend represents the current gold standard in growth hormone optimization technology.
Date: 2025-11-07
Result: 5.93 mg / 4.96 mg
CJC 1295 with DAC (Drug Affinity Complex) provides continuous GH release over several days, creating stable elevated levels. CJC 1295 without DAC (like in this blend) produces pulsatile releases that mimic natural GH secretion patterns. The No DAC version is generally preferred for athletic applications as it maintains natural rhythm, reduces side effects, and prevents receptor desensitization while still providing significant benefits.
This blend stimulates your body's natural GH production rather than introducing exogenous hormone. This maintains physiological pulsatility, reduces side effects like carpal tunnel and joint pain, and is more cost-effective. While results may be slightly more gradual than pharmaceutical GH, the safety profile, natural secretion pattern, and absence of shutdown make this blend preferable for many athletes.
Pre-bedtime injections are most effective as they align with the body's largest natural GH pulse during deep sleep. Some users also benefit from fasted morning injections. The key is consistency and empty stomach administration (at least 30 minutes before eating or 2 hours after meals). Avoid post-workout injections when blood sugar may be elevated, as this can blunt the GH response.
Yes, the CJC 1295 No DAC/Ipamorelin blend is excellent for extended use due to its pulsatile nature that prevents receptor desensitization. Many users maintain protocols for 6-12 months or longer with continuous benefits. Cycling (8-16 weeks on, 4 weeks off) may help maintain optimal responsiveness, but extended use is generally safe and effective with proper dosing.
Most users notice initial improvements in recovery, sleep quality, and skin appearance within 2-3 weeks. Visible changes in body composition typically become apparent after 4-6 weeks, with significant muscle definition and fat loss results evident by 8-12 weeks. The rate of results depends on dosage, consistency, diet, training intensity, and individual responsiveness to GH stimulation.
Please log in to write CJC 1295 No DAC 5 mg/Ipamorelin 5 mg review.
Classification: Growth Hormone Secretagogue (GHRP)
Active substance: Ipamorelin
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous (SC) Injection
Lab Test: View Result
Classification: Synthetic Melanocortin Peptide
Active substance: Melanotan II
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 10 mg per vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstituted with Bacteriostatic Water)
Lab Test: View Result
Classification: Metabolic Peptide (GLP-1/GIP Receptor Agonist)
Active substance: Tirzepatide
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstitution Required)
Lab Test: View Result
Classification: Nootropic Peptide
Active substance: Semax
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 5 mg per 2 mL vial
Pack size: 1 Vial
Route: Intranasal or Subcutaneous
Lab Test: View Result